However, data are still limited on the temporal progression of abnormal laboratory findings, such as leukopenia, lymphopenia, thrombocytopenia, elevated lactate dehydrogenase (LDH), elevated aspartate aminotransferase (AST), elevated alanine aminotransferase (ALT), elevated creatine kinase (CK), and elevated C-reactive protein (CRP) and the roles each of these plays in predicting outcomes and complications. This evidence concerns the gene GPT and lymphopenia.